Diagnostics

A gene expression test is changing melanoma care by providing risk data beyond traditional staging, enabling more tailored treatment for patients.

A major investment aims to develop biomarkers for TAND, the neuropsychiatric challenges affecting most with TSC, offering new hope for families.

Biocon names 30-year veteran Shreehas Tambe as its new CEO, consolidating its biosimilar and generics arms to create a global biopharma powerhouse.

A French biopharma's leap in synthetic lipid production de-risks its lead drug, eyes a vast sepsis market, and creates new commercial avenues.

INNOVATE Corp. reports a 62% Q4 revenue surge, but a 'going concern' warning and looming debt have forced the company to explore selling key assets.

Patterson Companies appoints Gregg Kunes as Chief Digital Officer, signaling a major tech push to reshape the dental and animal health supply chains.

A Texas clinic is combining brain health therapy, facial rejuvenation, and body sculpting in a novel, 'whole person' approach to wellness and recovery.

Teamsters at a critical Lansing food safety firm will rally Friday, alleging unfair labor practices are derailing talks for a fair first contract.

An award-winning AI now verifies hospital meals, promising to reduce errors and improve patient safety one tray at a time. Here’s how it works.

A new national initiative aims to connect siloed dental records to the broader healthcare system, promising to improve patient safety and reduce costly care gaps.

A novel drug targeting aging cells shows early success in treating psoriasis, eczema, and skin aging, heralding a new era in dermatology.

Lumexa Imaging posted strong 2025 revenue and cut its debt, yet a surprise net loss and EPS miss sent its stock tumbling. What's next for the imaging giant?

The company's B-cell cancer assay has achieved stringent IVDR certification, navigating a complex landscape and gaining a key edge in Europe's market.

A new high-tech wellness center arrives in Boulder, offering cutting-edge services. But does the science support the high price of proactive health?

The digital health startup ranked in the top 100 for its revolutionary AI platform that tackles the silent, global threat of chronic kidney disease.

Growth equity firm SEMCAP launches a new fund with Unilever Prestige visionary Vasiliki Petrou, targeting the booming wellness and longevity market.

A pioneering lab is now using AI to improve diagnostic accuracy for complex prostate procedures, marking a major leap for AI in routine patient care.

With cash dwindling and no FDA approval, ENDRA is exploring a sale. Will its innovative TAEUS® liver scanner find a champion or fade into obscurity?

A new study reveals Kansas City University's $498.9M annual economic impact, fueling jobs and tackling critical physician shortages across the Midwest.

With CE Mark approval, Countable Labs brings single-molecule counting PCR to Europe, promising unprecedented precision for gene therapy and diagnostics.